N-{1-[5-(3-fluorophenyl)-1,3,4-thiadiazol-2-yl]ethyl}ethene-1-sulfonamide
Structure Info
- Chemspace ID
- CSSB21332165805 (In-Stock Building Blocks)
- IUPAC Name
- N-{1-[5-(3-fluorophenyl)-1,3,4-thiadiazol-2-yl]ethyl}ethene-1-sulfonamide
- Mol formula
- C12H12FN3O2S2
- Mol weight
- 313 Da
- Catalog Number(s)
- BBLS21332165805, EN300-54821384, bbls21332165805
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 1.73
- Heavy atoms count
- 20
- Rotatable bond count
- 4
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 0.166
- Polar surface area (Å)
- 72
- Hydrogen bond acceptors count
- 4
- Hydrogen bond donors count
- 1
![Chemical structure of N-{1-[5-(3-fluorophenyl)-1,3,4-thiadiazol-2-yl]ethyl}ethene-1-sulfonamide (C12H12FN3O2S2) - CSSB21332165805](/st/structure/200/825df00afb90e021c165a91c620c4c0f/CC%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DNN%253DC%2528S1%2529C1%253DCC%2528F%2529%253DCC%253DC1.png "C12H12FN3O2S2")
- Zoom the structure
- CSSB21332165805
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 732.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 767.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 802.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 836.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 871.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 1,707.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 2,525.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 3,746.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of N-[1-(5-phenyl-1,3,4-thiadiazol-2-yl)ethyl]ethene-1-sulfonamide - CSSB21332166242](/st/structure/200/b0905f20e28d4f77c74c0bdc4e93426b/CC%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DNN%253DC%2528S1%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of N-{1-[5-(2-fluorophenyl)-1,3,4-thiadiazol-2-yl]ethyl}ethene-1-sulfonamide - CSSB21332108937](/st/structure/200/ea91c68268a57d4bbf3d885733f48906/CC%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DNN%253DC%2528S1%2529C1%253DC%2528F%2529C%253DCC%253DC1.png)
![Chemical structure of N-[1-(4-methyl-2-phenyl-1,3-thiazol-5-yl)ethyl]ethene-1-sulfonamide - CSSB21332166255](/st/structure/200/d05c4850a0585ef6f4f0be4ef2130c40/CC%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DC%2528C%2529N%253DC%2528S1%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of N-{1-[5-(3-fluorophenyl)-1,3,4-thiadiazol-2-yl]ethyl}prop-2-enamide - CSSB00133052829](/st/structure/200/f876aa598cb2d4a6dadfdacc6f5dceb8/CC%2528NC%2528%253DO%2529C%253DC%2529C1%253DNN%253DC%2528S1%2529C1%253DCC%253DCC%2528F%2529%253DC1.png)
![Chemical structure of N-{1-[2-(4-fluorophenyl)-4-methyl-1,3-thiazol-5-yl]ethyl}ethene-1-sulfonamide - CSSB21332126135](/st/structure/200/ecf4c224cfee14f9b1dadc4313294655/CC%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DC%2528C%2529N%253DC%2528S1%2529C1%253DCC%253DC%2528F%2529C%253DC1.png)
![Chemical structure of N-[1-(4-phenyl-1,3-thiazol-2-yl)ethyl]ethene-1-sulfonamide - CSSB21332052168](/st/structure/200/d2f8d0fcb4965c75ddc7cf74df387a93/CC%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DNC%2528%253DCS1%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of 2-chloro-2-fluoro-N-{1-[5-(3-fluorophenyl)-1,3,4-thiadiazol-2-yl]ethyl}acetamide - CSSB21332118749](/st/structure/200/d23fb71b4f770167573049e15c4030a5/CC%2528NC%2528%253DO%2529C%2528F%2529Cl%2529C1%253DNN%253DC%2528S1%2529C1%253DCC%2528F%2529%253DCC%253DC1.png)
